Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyridines, pyrimidines, and pyrazines, as BTK inhibitors and uses thereof

Pyridines, pyrimidines, and pyrazines, as BTK inhibitors and uses thereof

US Patent 9738648 · Granted Aug 22, 2017

Estimated economic value: $79,902,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fused imidazopyridines as reversible inhibitors of Brutons Tyrosine Kinase (BTK)2025
Fused imidazopyridines as reversible inhibitors of Brutons Tyrosine Kinase (BTK)2025
Fused imidazopyridines as reversible inhibitors of Brutons Tyrosine Kinase (BTK)2025
Fused imidazopyridines as reversible inhibitors of Brutons Tyrosine Kinase (BTK)2025
KRAS G12D proteolysis targeting chimeras2025
Compounds and uses thereof2024
GCN2 inhibitors and uses thereof2024
GCN2 inhibitors and uses thereof2024
Carboxamide-pyrimidine derivatives as SHP2 antagonists2023
Pyrazole compounds as modulators of FSHR and uses thereof2022
Heteroaryl compounds as BTK inhibitors and uses thereof2021
Heteroaryl compounds as BTK inhibitors and uses thereof2021